During the past decade, San Bernardino Urological Associates conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 6 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 3 clinical trials were completed. i.e. 37.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "San Bernardino Urological Associates" #1 sponsor was "Ferring Pharmaceuticals" with 3 trials, followed by "Janssen Research & Development, LLC" with 3 trials sponsored, "LTN PHARMACEUTICALS, INC." with 3 trials sponsored, "Cell Genesys" with 2 trials sponsored and "GTx" with 2 trials sponsored. Other sponsors include 17 different institutions and companies that sponsored additional 26 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "San Bernardino Urological Associates" #1 collaborator was "Astellas Pharma Inc" with 1 trials as a collaborator, "Astellas Pharma US, Inc." with 1 trials as a collaborator, "Foundation Medicine" with 1 trials as a collaborator, "Hoosier Cancer Research Network" with 1 trials as a collaborator and "Manyak, Michael, M.D." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "San Bernardino Urological Associates" are "Prostate Cancer" (15 trials), "Metastatic Prostate Cancer" (3 trials), "Prostatic Hyperplasia" (2 trials), "Prostatic Neoplasms" (2 trials) and "Advanced Prostate Adenocarcinoma" (1 trials). Many other conditions were trialed in "San Bernardino Urological Associates" in a lesser frequency.

Most popular intervention types in "San Bernardino Urological Associates" are "Drug" (32 trials), "Biological" (4 trials), "Other" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Degarelix" (3 trials), "Enzalutamide" (3 trials), "Prednisone" (3 trials) and "Niraparib" (2 trials). Other intervention names were less common.

The vast majority of trials in "San Bernardino Urological Associates" are 31 trials for "Male" genders and 4 trials for "All" genders.

Currently, there are NaN active trials in "San Bernardino Urological Associates". undefined are not yet recruiting, 4 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 17 completed trials in San Bernardino Urological Associates, undefined suspended trials, and 9 terminated clinical trials to date.

Out of the total trials that were conducted in San Bernardino Urological Associates, 4 "Phase 1" clinical trials were conducted, 13 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 0 trials that are defined as “Not Applicable".